Archive
This is a library of Lhasa's blog articles.
Filter by Category
Filter by Author
- Alex Cayley
- Alex Harding
- Alison Reeves
- Alun Myden
- Anax Oliveira
- Andrew Thresher
- Ash Ali
- Chris Barber
- Crina Heghes
- Dave Yeo
- David Ponting
- Grace Kocks
- Hazel Gardiner
- Kelly Gallagher
- Laura Johnston
- Liz Covey-Crump
- Michael Burns
- Nik Marchetti
- Paul Imeson
- Pearl Saville
- Rachael Tennant
- Rachel Hemingway
- Rob Foster
- Scott McDonald
- Susanne Stalford
Filter by Product
less than 5 minutesIt Takes a Team to Build an Adverse Outcome Pathway
The saying goes, “It takes a village to raise a child”. This sentiment can be translated to the work we do at Lhasa Limited, particularly to the work which we put into building Adverse Outcome Pathways (AOPs). To echo the sentiment in Chris Barber’s previous blog post, The challenge of building QSAR models; it is easy to build an AOP, harder to build a useful AOP, and as for building an AOP you can trust? It takes a team.
Read about how we are building adverse outcome pathways (AOPs) at Lhasa in this blog post written by Dr. Susanne Stalford, Senior Scientist at Lhasa.
30 September 2020
less than 5 minutesMoving with the times; Lhasa’s cloud offerings
In a world where we are all striving for progress, technology is also advancing quickly.
Like many organisations across the life sciences industry – evidenced by the 82 Amazon Web Service (AWS) life sciences case studies - Lhasa has adopted cloud, Software as a Service (SaaS), options across three notable areas...
30 March 2021
5 minutesThe Application of Adverse Outcome Pathways (AOPs) for Risk Assessment (A Webinar Summary)
AOPs have the potential to be very powerful for the contextualisation of alternative assays and consequently for the management of alternative testing strategies. Read about what Lhasa is doing in this area in this blog piece written by Alun Myden, Senior Scientist at Lhasa.
03 July 2020
